• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Arcus Biosciences, Inc. Common Stock (NY:RCUS)

29.21 -1.38 (-4.51%)
Official Closing Price Updated: 7:00 PM EDT, Aug 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Arcus Biosciences, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Arcus Biosciences (NYSE:RCUS) Flashes a High-Quality Technical Breakout Setup ↗
August 27, 2026
Via Chartmill
News headline image
Arcus Biosciences to Participate in Three Upcoming Investor Conferences
August 26, 2026
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences (RCUS) Q2 2026 Earnings Call Transcript ↗
August 12, 2026
CEO Rosen targets casdatifan as $5B to $10B drug with no frontline competition. 
Via The Motley Fool
Topics Earnings
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
August 11, 2026
From Arcus Biosciences
Via Business Wire
Arcus Biosciences (NYSE:RCUS) Beats Q2 Estimates and Advances Casdatifan Pipeline ↗
August 05, 2026
Via Chartmill
Arcus Biosciences (NYSE:RCUS) Q1 Loss Narrows But Revenues Miss Estimates; Focus Shifts to Kidney Cancer Drug Casdatifan ↗
May 05, 2026
Via Chartmill
Arcus Biosciences Inc (NYSE:RCUS) Reports Mixed Q4 2025 Results as Pipeline Strategy Pivots to Casdatifan ↗
February 25, 2026
Via Chartmill
News headline image
Arcus Biosciences Q2 Earnings Call Highlights ↗
August 08, 2026
Arcus Biosciences (NYSE:RCUS) outlined plans to expand development of its casdatifan cancer program across multiple lines of clear cell renal cell carcinoma, or ccRCC, while reporting second-quarter... 
Via MarketBeat
Topics Earnings
News headline image
Arcus Biosciences Reports Second-Quarter 2026 Financial Results and Provides a Pipeline Update
August 05, 2026
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
July 27, 2026
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences Announces Clinical Supply Agreement with AVEO Oncology to Evaluate Casdatifan in Combination with Tivozanib for Advanced Kidney Cancer Patients
July 22, 2026
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences and Summit Therapeutics Enter into Clinical Trial Collaboration to Evaluate Casdatifan Combined with Ivonescimab in Kidney Cancer
July 22, 2026
From Summit Therapeutics
Via Business Wire
News headline image
Arcus Biosciences to Host Conference Call to Discuss Second-Quarter 2026 Financial Results and Pipeline Updates
July 21, 2026
From Arcus Biosciences
Via Business Wire
News headline image
An Arcus Insider Sold 68,569 Shares but Kept 1.2 Million After a 200% Run ↗
July 13, 2026
This sale was executed under a Rule 10b5-1 plan following a 203% one-year surge. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
July 09, 2026
From Arcus Biosciences
Via Business Wire
News headline image
New Research Published in Nature Links Clinical Activity with HIF‑2a Biology in Advanced Kidney Cancer Patients Treated with Casdatifan
July 01, 2026
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
June 24, 2026
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
June 09, 2026
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences Announces Clinical Trial Collaboration and Supply Agreement to Evaluate Casdatifan in Combination with PD‑L1/VEGF‑A Bispecific Immunomodulator to Treat Kidney Cancer
June 03, 2026
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
May 26, 2026
From Arcus Biosciences
Via Business Wire
News headline image
Arcus (RCUS) Q1 2026 Earnings Call Transcript ↗
May 05, 2026
Arcus (RCUS) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Arcus Biosciences Reports First-Quarter 2026 Financial Results and Provides a Pipeline Update
May 05, 2026
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
April 24, 2026
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2026 Financial Results and Pipeline Updates
April 21, 2026
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
April 09, 2026
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
March 24, 2026
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
March 09, 2026
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences to Participate in Two Upcoming Investor Conferences
February 26, 2026
From Arcus Biosciences
Via Business Wire
News headline image
Arcus (RCUS) Q4 2025 Earnings Call Transcript ↗
February 25, 2026
Arcus (RCUS) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Arcus Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides a Pipeline Update
February 25, 2026
From Arcus Biosciences
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap